Search - tctmd.com

Displaying 21 - 40 of 44

Sort: Relevancy | Date

Presentation TCT 2018

How to Optimize Success in Crossing Tibial Occlusions

Presenter: Ehrin J. Armstrong, Sahil A. Parikh, Larry J. Diaz-Sandoval

September 22, 2018

Presentation TCT 2018

Disparities in Critical Limb Ischemia Treatment: Can We Minimize Variation?

Presenter: Ehrin J. Armstrong, Sahil A. Parikh, Schuyler Jones

September 22, 2018

Presentation TCT 2018

How the Best-CLI Trial Will Change Clinical Practice

Presenter: Ehrin J. Armstrong, Sahil A. Parikh, Matthew T. Menard

September 22, 2018

Presentation TCT 2018

Multidisciplinary Care in CLI: How Do We Accomplish It?

Presenter: Ehrin J. Armstrong, Sahil A. Parikh, Michael R. Jaff

September 22, 2018

Presentation TCT 2018

Case #5: Pedal Loop Reconstruction for Critical Limb Ischemia

Presenter: Herbert D. Aronow, Brian G. DeRubertis, Philip Green, Osamu Iida, Andrew J. Klein, Arthur C. Lee, Matthew T. Menard, Kenneth Rosenfield

September 22, 2018

Presentation TCT 2018

PCI for Ischemia Part I: Critical Analysis of the FAME Trials and ORBITA

Presenter: David J. Cohen, Sunil V. Rao, Bernard J. Gersh

September 22, 2018

Presentation TCT 2018

Three-year Outcomes of Surgical Vs. Endovascular Revascularization for Critical Limb Ischemia: The SPINACH Study

Presenter: Osamu Iida, Shigeru Saito

September 21, 2018

Presentation TCT 2018

TCT-115: Long-Term Follow-up of the PADI Trial: Percutaneous Transluminal Angioplasty Versus Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia

Presenter: J. Michael Bacharach, Tony Das, Thijs Wakkie

September 21, 2018

Presentation TCT 2018

Case Introduction: Critical Limb Ischemia

Presenter: Michelle Maier, Julie Logan, Sameer Nagpal, Samit Shah

September 21, 2018

Presentation TCT 2018

Percutaneous Deep Vein aRterialization for the Treatment of Late Stage Critical LiMb ISchEmia, The PROMISE Trial: Early Feasibility Interim Results (LimFlow)

Presenter: George L Adams, Tony Das, Steve Henao

September 21, 2018

Presentation TCT 2018

Clinical Outcomes of Sirolimus-Eluting Bioresorbable Peripheral Scaffold System in Subjects with Critical Limb Ischemia Disease due to De Novo Lesions (Meril)

Presenter: George L Adams, Tony Das, Gireesh Warwadekar

September 21, 2018

News Daily News

‘Immediate’ Return to Normal Flow Post-PCI in ORBITA-Like Patients

Michael O'Riordan

August 23, 2018

News Daily News

CKD Patients With Left Main Disease See Similar Outcomes at 3 Years After PCI vs CABG: EXCEL

Caitlin E. Cox

August 09, 2018

News Daily News

Once Again, ISCHEMIA Trial Feels the Squeeze

Michael O'Riordan

June 29, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2018

Caitlin E. Cox

June 01, 2018

News Conference News EuroPCR 2018

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

Shelley Wood

May 22, 2018

News Daily News

RANGER-SFA Data Support Another Paclitaxel-Coated Balloon for Superficial Femoral Artery Disease

L.A. McKeown

May 08, 2018

News Daily News

Quicker Diuretics Not Associated With Better Outcomes in Acute Heart Failure

Todd Neale

March 25, 2018

Presentation ACC 2018

A Phase II Randomized Double-Blind, Placebo Controlled Study in Patients with Critical Limb Ischemia to Evaluate the Safety and Efficacy of hSDF-1 plasmid (JVS-100) Post Open or Endovascular Revascularization (STOP-PAD Trial)

Presenter: Mehdi H. Shishehbor

March 12, 2018

ACC 2018, Day Three: Gout, Hypertension, and Diabetes Dominate Opening Late Breaker

News Conference News ACC 2018

ACC 2018, Day Three: Gout, Hypertension, Diabetes, PFO Closure, DAPT, NOAC Reversal, and More

Shelley Wood

March 12, 2018

Advertisement

How to Optimize Success in Crossing Tibial Occlusions

Disparities in Critical Limb Ischemia Treatment: Can We Minimize Variation?

How the Best-CLI Trial Will Change Clinical Practice

Multidisciplinary Care in CLI: How Do We Accomplish It?

Case #5: Pedal Loop Reconstruction for Critical Limb Ischemia

PCI for Ischemia Part I: Critical Analysis of the FAME Trials and ORBITA

Three-year Outcomes of Surgical Vs. Endovascular Revascularization for Critical Limb Ischemia: The SPINACH Study

TCT-115: Long-Term Follow-up of the PADI Trial: Percutaneous Transluminal Angioplasty Versus Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia

Case Introduction: Critical Limb Ischemia

Percutaneous Deep Vein aRterialization for the Treatment of Late Stage Critical LiMb ISchEmia, The PROMISE Trial: Early Feasibility Interim Results (LimFlow)

Clinical Outcomes of Sirolimus-Eluting Bioresorbable Peripheral Scaffold System in Subjects with Critical Limb Ischemia Disease due to De Novo Lesions (Meril)

‘Immediate’ Return to Normal Flow Post-PCI in ORBITA-Like Patients

CKD Patients With Left Main Disease See Similar Outcomes at 3 Years After PCI vs CABG: EXCEL

Once Again, ISCHEMIA Trial Feels the Squeeze

TCTMD’s Top 10 Most Popular Stories for May 2018

New ORBITA Insights: Invasive Physiology Tests Track Closely With Ischemia, but Not Symptom Improvement

RANGER-SFA Data Support Another Paclitaxel-Coated Balloon for Superficial Femoral Artery Disease

Quicker Diuretics Not Associated With Better Outcomes in Acute Heart Failure

A Phase II Randomized Double-Blind, Placebo Controlled Study in Patients with Critical Limb Ischemia to Evaluate the Safety and Efficacy of hSDF-1 plasmid (JVS-100) Post Open or Endovascular Revascularization (STOP-PAD Trial)

ACC 2018, Day Three: Gout, Hypertension, Diabetes, PFO Closure, DAPT, NOAC Reversal, and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content